Financial Assistance for Your Rheumatoid Arthritis Medications

The Kineret® and Kepivance® Patient Assistance Program

P.O. Box 13185, La Jolla, CA 92039-3185
Phone: (866) 547-0644 for reimbursement assistance
Fax: (866) 549-7219
Application: http://www.kineretrx.com/pdf/Kineret_PAP_Application_Form.pdf
Program website: http://www.kineretrx.com/patient

Abatacept (Orencia)
The ORENCIA Promise Program is a copay program for new ORENCIA patients with private health insurance that covers medication costs for ORENCIA.  To be eligible, you must be new to treatment with ORENCIA (are no currently taking ORENCIA or have not taken ORENCIA in the past 6 months).  This program is not open to uninsured patients or for patients whose prescriptions are reimbursed under Medicare, Medicaid, or similar federal or state programs or private insurance in the Commonwealth of Massachusetts.

“The ORENCIA Program Program pays the full copay for ORENCIA for the first 6 months of therapy (8 infusions).  Plus, if you are not satisfied after 6 months, we’ll pay your first copay of another RA medicine, up to $500.”

Phone: (800) 675-8416 for copayment assistance
Phone: (866) 268-4514 for reimbursement assistance and uninsured or underinsured assistance
Program website: https://www.theorenciapromiseprogram.com/orencia/registration.jsp

Bristol-Myers Squibb Patient Assistance Foundation, Inc. (ORENCIA®)

To qualify, you must not have prescription drug coverage or receive any benefits that help you pay for prescription drugs, such as Medicaid, Medicare Part D, state sponsored prescription drug programs, employee, military, retirement, or pension program drug coverage.  Please note that pharmacy discount cards or drug company patient assistance programs are not considered to be prescription drug coverage and if you participate in these programs you still may qualify for assistance.

Bristol-Myers Squibb Patient Assistance Foundation, Inc. (ORENCIA®)

P.O. Box 991, Somerville, NJ 08876

Phone: (800) 736-0003 Option 4
Fax: (866) 694-2545
Application: http://www.needymeds.org/papforms/brisor1073.pdf
Program website: http://www.bmspaf.org/program5.html

Leflunomide (Arava)
Sanofi-Aventis Patient Assistance Program
Application: http://www.needymeds.org/papforms/sanofi0150.pdf

The patient cannot have prescription insurance, be ineligible for any federal or state programs and have an income at or below 250% of the Federal Poverty Level. Medical diagnosis necessary for this program is not specified. The patient must also be a US resident. Patients with Medicare Part D are not eligible, however, if they have Part D and are still having problems affording the medication, they may apply. Sanofi Aventis may help patients in the donut hole. They will initially deny patient but submit an appeal and state that patient is in the DH and has no coverage.

Mycophenolate mofetil (CellCept)
Roche Reimbursement and Patient Assistance Program